Cover Image
市場調查報告書

泌尿生殖系統系醫藥品的全球市場

Genito-Urinary Drugs Global Market Report 2018

出版商 The Business Research Company 商品編碼 531328
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
泌尿生殖系統系醫藥品的全球市場 Genito-Urinary Drugs Global Market Report 2018
出版日期: 2018年02月01日 內容資訊: 英文 125 Pages
簡介

本報告提供全球泌尿生殖系統系醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 泌尿生殖系統系醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 荷爾蒙避孕藥
    • 前列腺肥大症用醫藥品
    • 不孕症用醫藥品
    • ED治療藥
    • 尿失禁·膀胱過動症用醫藥品
    • 感染疾病其他的醫藥品
    • 荷爾蒙補充療法用醫藥品
    • 利尿劑
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 泌尿生殖系統系醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 全球產科醫生·婦科醫生數:各國
  • 市場收益 vs 產科醫生·婦科醫生數:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Bayer Ag

第18章 主要M&A:泌尿生殖系統系醫藥品市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Genito-Urinary Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs market.

Where is the largest and fastest growing market for the genito-urinary drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genito-urinary drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The genito-urinary drugs market section of the report gives context. It compares the genito-urinary drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Genito-Urinary Drugs Indicators Comparison.

Scope:

Markets Covered: Hormonal contraceptives; Drugs For Hormonal Replacement Therapy; Drugs For Infections And Others; Drugs for Benign prostatic hypertrophy; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs for Infertility; Diuretics

Companies Mentioned: Daiichi Sankyo Company, Limited,Pfizer Inc,Bayer AG,Astellas Pharma Inc,Allergan Plc

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Genito-Urinary Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

1. Genito-Urinary Drugs Market Characteristics

2. Genito-Urinary Drugs Market Size And Growth

  • 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth, Value ($ Billion)
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Genito-Urinary Drugs Trends And Strategies

4. Pestle Analysis

  • 4.1. Political
  • 4.2. Economic
  • 4.3. Social
  • 4.4. Technological
  • 4.5. Legal
  • 4.6. Environmental

5. Genito-Urinary Drugs Market Customer Information

6. Genito-Urinary Drugs Market Regional And Country Analysis

  • 6.1. Global Genito-Urinary Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  • 6.2. Global Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  • 6.3. Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Region
  • 6.4. Global Genito-Urinary Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  • 6.5. Global Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  • 6.6. Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Country

7. Genito-Urinary Drugs Market Segmentation

  • 7.1. Global Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

  • 7.2. Global Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. Genito-Urinary Drugs Market Segments

  • 8.1.Hormonal contraceptives

a) Market Characteristics

b) Market Trends & Strategies

c) Global Hormonal contraceptives Market, 2017, By Segment, Value ($ Billion)

  • 8.2.Drugs For Hormonal Replacement Therapy

a) Market Characteristics

b) Market Trends & Strategies

c) Global Drugs For Hormonal Replacement Therapy Market, 2017, By Segment, Value ($ Billion)

  • 8.3.Drugs For Infections And Others

a) Market Characteristics

b) Market Trends & Strategies

c) Global Drugs For Infections And Others Market, 2017, By Segment, Value ($ Billion)

  • 8.4.Drugs for Benign prostatic hypertrophy

a) Market Characteristics

b) Market Trends & Strategies

c) Global Drugs for Benign prostatic hypertrophy Market, 2017, By Segment, Value ($ Billion)

  • 8.5.Drugs For Erectile Dysfunction

a) Market Characteristics

b) Market Trends & Strategies

c) Global Drugs For Erectile Dysfunction Market, 2017, By Segment, Value ($ Billion)

  • 8.6.Drugs For Urinary Incontinence And Overactive Bladder

a) Market Characteristics

b) Market Trends & Strategies

c) Global Drugs For Urinary Incontinence And Overactive Bladder Market, 2017, By Segment, Value ($ Billion)

  • 8.7.Drugs for Infertility

a) Market Characteristics

b) Market Trends & Strategies

c) Global Drugs for Infertility Market, 2017, By Segment, Value ($ Billion)

  • 8.8.Diuretics

a) Market Characteristics

b) Market Trends & Strategies

c) Global Diuretics Market, 2017, By Segment, Value ($ Billion)

9. Global Genito-Urinary Drugs Market Comparison With Macro Economic Factors

  • 9.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, Global
  • 9.2. Per Capita Average Genito-Urinary Drugs Expenditure, Global

10. Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries

  • 10.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country
  • 10.2. Per Capita Average Genito-Urinary Drugs Expenditure, By Country

11. Genito-Urinary Drugs Market Comparison With Industry Metrics

  • 11.1. Global Number Of Pharmacists, 2017, By Country
  • 11.2. Global Genito-urinary Disorders Market Revenue Versus Number Of Pharmacists, 2017, By Country
  • 11.3. Global Number Of Pharma Enterprises, 2017, By Country
  • 11.4. Global Genito-urinary Disorders Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
  • 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
  • 11.6. Global Genito-urinary Disorders Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
  • 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.8. Global Genito-urinary Disorders Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.9. Prevalent Cases of Contraceptives, 2015, By Country
  • 11.10. Global Number Of Obstetricians And Gynaecologists 2017, By Country
  • 11.11. Global Genito-urinary Disorders Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2017, By Country
  • 11.12. Global Number Of General Practitioners 2017, By Country
  • 11.13. Global Genito-urinary Disorders Market Revenue Versus Number Of General Practitioners, 2017, By Country

12. Asia-Pacific Genito-Urinary Drugs Market

    • 12.1.1. Asia-Pacific Genito-Urinary Drugs Market Overview
    • 12.1.2. Asia-Pacific Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.1.3. Asia-Pacific Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.1.4. Asia-Pacific Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 12.1.5. Asia-Pacific Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.2. Asia-Pacific Genito-Urinary Drugs Market: Country Analysis
  • 12.3. China Genito-Urinary Drugs Market
    • 12.3.1. China Genito-Urinary Drugs Market Overview
    • 12.3.2. China Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.3.3. China Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.3.4. China Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 12.3.5. China Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.4. India Genito-Urinary Drugs Market
    • 12.4.1. India Genito-Urinary Drugs Market Overview
    • 12.4.2. India Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.4.3. India Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.4.4. India Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 12.4.5. India Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.5. Japan Genito-Urinary Drugs Market
    • 12.5.1. Japan Genito-Urinary Drugs Market Overview
    • 12.5.2. Japan Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.5.3. Japan Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.5.4. Japan Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 12.5.5. Japan Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.6. Australia Genito-Urinary Drugs Market
    • 12.6.1. Australia Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.6.2. Australia Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.6.3. Australia Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 12.6.4. Australia Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. Western Europe Genito-Urinary Drugs Market

    • 13.1.1. Western Europe Genito-Urinary Drugs Market Overview
    • 13.1.2. Western Europe Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.1.3. Western Europe Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.1.4. Western Europe Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 13.1.5. Western Europe Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.2. Western Europe Genito-Urinary Drugs Market: Country Analysis
  • 13.3. UK Genito-Urinary Drugs Market
    • 13.3.1. UK Genito-Urinary Drugs Market Overview
    • 13.3.2. UK Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.3.3. UK Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.3.4. UK Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 13.3.5. UK Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.4. Germany Genito-Urinary Drugs Market
    • 13.4.1. Germany Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.4.2. Germany Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.4.3. Germany Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 13.4.4. Germany Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.5 France Genito-Urinary Drugs Market
    • 13.5.1 France Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.5.2 France Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.5.3. France Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 13.5.4. France Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.6. Italy Genito-Urinary Drugs Market
    • 13.6.1. Italy Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.6.2. Italy Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.6.3. Italy Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 13.6.4. Italy Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.7. Spain Genito-Urinary Drugs Market
    • 13.7.1. Spain Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.7.2. Spain Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.7.3. Spain Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 13.7.4. Spain Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Genito-Urinary Drugs Market

    • 14.1.1. Eastern Europe Genito-Urinary Drugs Market Overview
    • 14.1.2. Eastern Europe Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.1.3. Eastern Europe Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.1.4. Eastern Europe Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 14.1.5. Eastern Europe Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 14.2. Eastern Europe Genito-Urinary Drugs Market: Country Analysis
  • 14.3. Russia Genito-Urinary Drugs Market
    • 14.3.1. Russia Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.3.2. Russia Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.3.3. Russia Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 14.3.4. Russia Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. North America Genito-Urinary Drugs Market

    • 15.1.1. North America Genito-Urinary Drugs Market Overview
    • 15.1.2. North America Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.1.3. North America Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.1.4. North America Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 15.1.5. North America Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 15.2. North America Genito-Urinary Drugs Market: Country Analysis
  • 15.3. USA Genito-Urinary Drugs Market
    • 15.3.1. USA Genito-Urinary Drugs Market Overview
    • 15.3.2. USA Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.3.3. USA Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.3.4. USA Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 15.3.5. USA Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. South America Genito-Urinary Drugs Market

    • 16.1.1. South America Genito-Urinary Drugs Market Overview
    • 16.1.2. South America Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.1.3. South America Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.1.4. South America Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 16.1.5. South America Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 16.2. South America Genito-Urinary Drugs Market: Country Analysis
  • 16.3. Brazil Genito-Urinary Drugs Market
    • 16.3.1. Brazil Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.3.2. Brazil Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.3.3. Brazil Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 16.3.4. Brazil Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. Middle East Genito-Urinary Drugs Market

    • 17.1.1. Middle East Genito-Urinary Drugs Market Overview
    • 17.1.2. Middle East Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 17.1.3. Middle East Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 17.1.4. Middle East Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 17.1.5. Middle East Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. Africa Genito-Urinary Drugs Market

    • 18.1.1. Africa Genito-Urinary Drugs Market Overview
    • 18.1.2. Africa Genito-Urinary Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 18.1.3. Africa Genito-Urinary Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 18.1.4. Africa Genito-Urinary Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Hormonal contraceptives

Drugs For Hormonal Replacement Therapy

Drugs For Infections And Others

Drugs for Benign prostatic hypertrophy

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs for Infertility

Diuretics

    • 18.1.5. Africa Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. Genito-Urinary Drugs Market Competitive Landscape

  • 19.1. Company Profiles
  • 19.2. Daiichi Sankyo Company, Limited
    • 19.2.1. Overview
    • 19.2.2. Products And Services
    • 19.2.3. Strategy
    • 19.2.4. Financial Performance
  • 19.3. Pfizer Inc
    • 19.3.1. Overview
    • 19.3.2. Products And Services
    • 19.3.3. Strategy
    • 19.3.4. Financial Performance
  • 19.4. Bayer AG
    • 19.4.1. Overview
    • 19.4.2. Products And Services
    • 19.4.3. Strategy
    • 19.4.4. Financial Performance
  • 19.5. Astellas Pharma Inc
    • 19.5.1. Overview
    • 19.5.2. Products And Services
    • 19.5.3. Strategy
    • 19.5.4. Financial Performance
  • 19.6. Allergan Plc
    • 19.6.1. Overview
    • 19.6.2. Products And Services
    • 19.6.3. Strategy
    • 19.6.4. Financial Performance

20. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market

21. Market Background: Genito-Urinary Drugs Market

    • 21.1.1. Genito-Urinary Drugs Market Characteristics
    • 21.1.2. Genito-Urinary Drugs Market Historic Growth, Value ($ Billion)
      • 21.1.2.1. Drivers Of The Market
      • 21.1.2.2. Restraints Of The Market
    • 21.1.3. Genito-Urinary Drugs Market Forecast Growth, Value ($ Billion)
      • 21.1.3.1. Drivers Of The Market
      • 21.1.3.2. Restraints Of The Market
    • 21.1.4. Genito-Urinary Drugs Trends And Strategies
  • 21.2. Genito-Urinary Drugs Market Regional And Country Analysis
    • 21.2.1. Global Genito-Urinary Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
    • 21.2.2. Global Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, By Region
    • 21.2.3. Genito-Urinary Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
    • 21.2.4. Genito-Urinary Drugs Market, 2013 - 2021, Historic And Forecast, By Country
    • 21.2.5. Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Segment
    • 21.2.6. Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Country And Segment
  • 21.3. Global Genito-Urinary Drugs Market Comparison With Macro Economic Factors
    • 21.3.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, Global
    • 21.3.2. Per Capita Average Genito-Urinary Drugs Expenditure, Global
  • 21.4. Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries
    • 21.4.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country
    • 21.4.2. Per Capita Average Genito-Urinary Drugs Expenditure, By Country
  • 21.5. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market

22. Appendix

  • 22.1. NAICS Definitions Of Industry Covered In This Report
  • 22.2. Abbreviations
  • 22.3. Currencies
  • 22.4. Research Inquiries
  • 22.5. The Business Research Company
  • 22.6. Copyright And Disclaimer
Back to Top